Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.5K

Risk of seizure recurrences after first unprovoked seizure during childhood

M S Bessisso1, M F El-Said, N A Almula

  • 1Department of Pediatrics, Hamad General Hospital, PO Box 3050, Doha, Qatar. Fax. 00 974 439 2204.

Neurosciences (Riyadh, Saudi Arabia)
|November 5, 2013
PubMed

Insights

Seizure recurrence after a first unprovoked attack in children is higher if risk factors are present. Awareness of these factors is crucial for treatment decisions.

Area of Science:

  • Pediatrics
  • Neurology
  • Clinical Medicine

Background:

  • First unprovoked seizures in children under 12 require understanding recurrence risks.
  • Identifying predictors of seizure recurrence is vital for appropriate management.

Purpose of the Study:

  • To determine the incidence of seizure recurrence after a first unprovoked seizure in children under 12.
  • To identify significant risk factors associated with seizure recurrence in this pediatric population.

Main Methods:

  • A prospective study followed 33 children (2 months-12 years) after their first unprovoked seizure.
  • Exclusion criteria included seizures due to fever, metabolic issues, trauma, and specific epilepsy syndromes.
  • Risk factors assessed included sex, age, family history, developmental delay, seizure characteristics, neurological findings, and EEG results.

Main Results:

  • The overall recurrence rate was 33% (11 out of 33 patients).
  • Significant risk factors for recurrence included abnormal electroencephalograms (EEG), positive family history of epilepsy, and cluster onset seizures.
  • The presence of one or more risk factors significantly increased the likelihood of recurrence.

Conclusions:

  • Children with one or more identified risk factors have a higher incidence of seizure recurrence.
  • Informing patients and families about recurrence risk is essential for shared decision-making regarding post-first seizure treatment.
Abstract

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

8.1K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.8K

Related Concept Videos

Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
43
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
73
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.8K
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
44
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K